Case studies

The 2017 Access to Vaccines Index has mapped how vaccine companies are responding to global calls to improve immunisation coverage. Here the Index presents three case studies, covering the first malaria and dengue vaccines and emerging infectious diseases such as the Ebola virus and Zika virus.

Got a question?

Learn more

View our detailed overview of each company’s performance in the Index